Hsp90 inhibitor AUY922

DRUG3 trials

Sponsors

Northwestern University, Dale Shepard, MD, PhD, Jonsson Comprehensive Cancer Center

Conditions

Adenocarcinoma of the LungNon-small Cell Lung CancerRecurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IV Non-small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

CompletedNCT01259089

Northwestern UniversityAdenocarcinoma of the Lung, Non-small Cell Lung Cancer

Start: 2011-04-27End: 2014-09-29Updated: 2019-09-11

Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies

TerminatedNCT01602627

Dale Shepard, MD, PhDUnspecified Adult Solid Tumor, Protocol Specific

Start: 2011-09-30End: 2012-02-29Updated: 2013-02-07

Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer

CompletedNCT01784640

Jonsson Comprehensive Cancer CenterRecurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer

Start: 2014-01-31End: 2018-10-11Updated: 2020-09-03